RGS16 promotes glioma progression and serves as a prognostic factor.
Ruoyu HuangGuanzhang LiZheng ZhaoFan ZengKenan ZhangYanwei LiuKuanyu WangHuimin HuPublished in: CNS neuroscience & therapeutics (2020)
RGS16 plays an important role in glioma progression and serves as an independent prognostic factor, especially in GBM patients.